// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

INTENSIVE BLOOD PRESSURE CONTROL AND OUTCOMES IN HYPERTENSIVE PATIENTS WITH DYSGLYCEMIA – STUDY OF GLASGOW BP CLINIC AND SPRINT DATA

Llano, A - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

SYSTEMATIC REVIEW AND META-ANALYSES OF BLOOD PRESSURE RESPONSE TO ANTIHYPERTENSIVE MONOTHERAPY IN RANDOMISED CONTROLLED TRIALS

Alsanosi, S - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Angiotensin II

THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE AND HYPERTENSION

Brugts, J - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Perindopril

URINARY PROTEOMICS PREDICTS MORTALITY IN TYPE 2 DIABETES PATIENTS WITH MICROALBUMINURIA

Currie, G - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

A URINARY FRAGMENT OF MUCIN 1 SUBUNIT ALPHA IS A NOVEL BIOMARKER PREDICTING RENAL DYSFUNCTION IN THE GENERAL POPULATION

Zhang, Z - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

SERUM CHLORIDE IS A MORTALITY RISK PREDICTOR IN TYPE 2 DIABETES MELLITUS – ANALYSIS OF 91,159 PATIENTS IN THE WEST OF SCOTLAND

McCallum, L - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

EFFECTS OF RENAL DENERVATION IN PATIENTS WITH VERSUS WITHOUT CHRONIC KIDNEY DISEASE ( RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY WITH FOLLOW-UP DATA OF 3 YEARS )

Ott, C - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

THE EFFECTS OF LCZ696 ON LEFT VENTRICULAR REMODELING IN HYPERTENSIVE PATIENTS – RESULTS OF A DOUBLE BLIND, RANDOMIZED, MULTICENTER TRIAL

Ott, C - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Olmesartan medoxomil

ATTENUATION OF SPLANCHNIC AUTOTRANSFUSION FOLLOWING NON-INVASIVE ULTRASOUND RENAL DENERVATION ( A NOVEL MARKER OF PROCEDURAL SUCCESS )

Saxena, M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

SERUM CHLORIDE AND ADVERSE CARDIOVASCULAR EVENTS IN THE ANGLO SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT)

McCallum, L - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Amlodipine

METABOLOMICS PROFILING OF SERUM ELECTROLYTES SHOW A FATTY ACID ENRICHMENT FOR SERUM POTASSIUM LEVELS

Menni, C - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

DETRIMENTAL EFFECT ASSOCIATED WITH THE USE OF MORE THAN THREE DRUG CLASSES TO ACHIEVE BLOOD PRESSURE CONTROL IN SPRINT

McCallum, L - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

NORADRENERGIC RECEPTOR FUNCTION IN HEALTHY AND OBESE PERIVASCULAR ADIPOSE TISSUE

Saxton, S - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Nitric oxide

THE HAEMODYNAMIC MECHANISM OF THE AGE-RELATED INCREASE IN PULSE PRESSURE IN WOMEN

Li, Y - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

PULSE PRESSURE AMPLIFICATION USING 24-HOUR AMBULATORY BLOOD PRESSURE

Pikilidou, M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

IMBALANCE BETWEEN T REGULATORY AND TH17 LYMPHOCYTE SUBSETS IN PATIENTS WITH RESISTANT HYPERTENSION AND PRIMARY ALDOSTERONISM

Kaszuba, A - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Angiotensin II

MASKED-UNCONTROLLED HYPERTENSION MANAGEMENT BASED ON OFFICE BP OR ON OUT-OF-OFFICE (AMBULATORY) BP MEASUREMENT (MASTER) ( STUDY PROTOCOL )

Parati, G - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

REDO RENAL DENERVATION WITH NON-INVASIVE THERAPEUTIC ULTRASOUND

Ormiston, J - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

RENAL DENERVATION USING THE ENLIGHTN RENAL DENERVATION SYSTEM IN ALTERNATIVE HYPERTENSIVE POPULATIONS ( 36 MONTH BLOOD PRESSURE RESULTS FROM ENLIGHTN II STUDY )

Lobo, M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

INTER-ARM BLOOD PRESSURE DIFFERENCE IN AN UNSELECTED HYPERTENSIVE POPULATION

Kladas, G - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved